Morning Briefing: Markets mixed as dollar gains, commodities slip

Morning Briefing: Markets mixed as dollar gains, commodities slip

Morning Briefing: Markets mixed as dollar gains, commodities slip

Markets mixed as dollar gains, commodities slip

World stock markets are mixed so far Thursday while commodities have eased from gains in the previous session as the US dollar regains some lost value.

Asian markets closed lower but Sydney’s ASX closed higher following a rise in job vacancies and new home sales. Investors in the region were digesting the potential impact of the official start of the Brexit process and how both the UK and EU economies may be affected down the line.

Brexit is a key focus in Europe of course but most major indexes are trending higher. A media report suggests that the European Central Bank wants to give reassurance that it will continue its easy-money policy.

European markets are also considering data from the Eurozone showing reduction in some key confidence metrics; German CPI is due later.

Wall Street and Toronto are expected to open lower. US GDP and Canadian Industrial Product and Raw Materials data is due.

 

Latest

1 month ago

1 year ago

 

North America (previous session)

US Dow Jones

20,659.32 (-0.20 per cent)

-0.73 per cent

+16.61 per cent

TSX Composite

15,657.63 (+0.38 per cent)

+1.68 per cent

+15.95 per cent

 

Europe (at 5.00am ET)

UK FTSE

7,379.46 (+0.08 per cent)

+1.60 per cent

+18.96 per cent

German DAX

12,224.88 (+0.18 per cent)

+3.30 per cent

+21.68 per cent

 

Asia (at close)

China CSI 300

3,436.76 (-0.82 per cent)

+0.46 per cent

+6.86 per cent

Japan Nikkei

19,063.22 (-0.80 per cent)

-0.29 per cent

+12.94 per cent

 

Other Data (at 5.00am ET)

Oil (Brent)

Oil (WTI)

Gold

Can. Dollar

52.18

(-0.46 per cent)

49.40

(-0.22 per cent)

1249.80

(-0.31 per cent)

U$0.7496

 

Aus. Dollar

U$0.7661

Ackman says Valeant investment was a mistake

Hedge fund investor Bill Ackman has apologized to his clients for losing money on his fund’s investment in Canadian firm Valeant Pharmaceuticals.

In a letter seen by Reuters, Ackman says that he assumes 100 per cent responsibility for the “mistake” which he says “cost all of us a tremendous amount.”

His Pershing Square fund ditched its entire Valeant holding last month, losing $4 billion for which Ackman says he is “deeply and profoundly sorry.”


More market talk: